Dementias Completed Phase 2 Trials for CX516 (DB06247)

Also known as: Dementia / Dementia NOS / Amentia

IndicationStatusPhase
DBCOND0060453 (Dementias)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00001662Treatment of Alzheimer's Disease With CX516 (Ampalex)Treatment